Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of Leukocytes01:27

Disorders of Leukocytes

2.4K
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
2.4K
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

4.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
4.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Determinants of Total and Inhaled Allergen-Specific Immunoglobulin E in the Middle-Aged and Elderly Population.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2026
Same author

Adnexal necrobiotic xanthogranuloma presenting as a "kissing" eyelid lesion.

Orbit (Amsterdam, Netherlands)·2026
Same author

Impact of switching from the originator adalimumab to a biosimilar: a retrospective cohort study.

BMC immunology·2025
Same author

Improving organisation to improve care: ERN ReCONNET organisational reference model for systemic sclerosis patients' care pathway.

Journal of scleroderma and related disorders·2024
Same author

Safety and efficacy of subcutaneous iscalimab (CFZ533) in two distinct populations of patients with Sjögren's disease (TWINSS): week 24 results of a randomised, double-blind, placebo-controlled, phase 2b dose-ranging study.

Lancet (London, England)·2024
Same author

Histological evidence of MAPK pathway activation across subtypes of adult orbital xanthogranulomatous disease irrespective of the detection of oncogenic mutations.

Clinical immunology (Orlando, Fla.)·2024

Related Experiment Video

Updated: Mar 20, 2026

Analyzing the Functions of Mast Cells In Vivo Using 'Mast Cell Knock-in' Mice
09:07

Analyzing the Functions of Mast Cells In Vivo Using 'Mast Cell Knock-in' Mice

Published on: May 27, 2015

11.1K

[Systemic mastocytosis: a heterogeneous disease].

M A W Hermans1, M Verburg, J A M van Laar

  • 1Erasmus MC, Rotterdam.

Nederlands Tijdschrift Voor Geneeskunde
|May 28, 2016
PubMed
Summary

Systemic mastocytosis (SM) is a rare disease of mast cell proliferation. Early diagnosis is crucial for managing symptoms and preventing severe complications like anaphylaxis.

More Related Videos

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling
09:08

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling

Published on: October 14, 2021

6.4K
Isolation of Peritoneum-derived Mast Cells and Their Functional Characterization with Ca2+-imaging and Degranulation Assays
11:31

Isolation of Peritoneum-derived Mast Cells and Their Functional Characterization with Ca2+-imaging and Degranulation Assays

Published on: July 4, 2018

13.0K

Related Experiment Videos

Last Updated: Mar 20, 2026

Analyzing the Functions of Mast Cells In Vivo Using 'Mast Cell Knock-in' Mice
09:07

Analyzing the Functions of Mast Cells In Vivo Using 'Mast Cell Knock-in' Mice

Published on: May 27, 2015

11.1K
Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling
09:08

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling

Published on: October 14, 2021

6.4K
Isolation of Peritoneum-derived Mast Cells and Their Functional Characterization with Ca2+-imaging and Degranulation Assays
11:31

Isolation of Peritoneum-derived Mast Cells and Their Functional Characterization with Ca2+-imaging and Degranulation Assays

Published on: July 4, 2018

13.0K

Area of Science:

  • Hematology
  • Oncology
  • Immunology

Background:

  • Systemic mastocytosis (SM) is an acquired myeloproliferative neoplasm characterized by aberrant mast cell proliferation.
  • The diverse clinical presentations of SM often lead to delayed diagnosis as patients may initially consult various medical specialists.
  • Physician unfamiliarity with SM contributes to diagnostic delays, increasing patient morbidity and risk of severe complications, including anaphylaxis.

Observation:

  • This report details two patient cases illustrating the heterogeneous clinical phenotypes observed in systemic mastocytosis.
  • The cases highlight the diagnostic challenges and varied presentations of SM.
  • Key diagnostic steps, including serum tryptase measurement and bone marrow biopsy, are emphasized.

Findings:

  • Serum tryptase levels are a useful initial diagnostic marker, but normal levels do not exclude SM.
  • A bone marrow biopsy is essential for the definitive diagnosis of systemic mastocytosis.
  • SM presents with a wide spectrum of symptoms and requires a comprehensive diagnostic approach.

Implications:

  • Increased physician awareness of SM's diverse presentations is critical for timely diagnosis.
  • Prompt diagnosis and management of SM can mitigate severe complications and improve patient outcomes.
  • Understanding the heterogeneous nature of SM informs current treatment strategies and future research directions.